13F-HR filed by JANUS HENDERSON GROUP PLC
JANUS HENDERSON GROUP PLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 2,518 holding rows worth $186,741,475,541.
- Accession
- 0001085146-24-003869
- Filer
- CIK 1274173
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 3,910 entries on the cover page, a total value of $186,741,475,541 stated on the cover page (in dollars after the unit check, H1), rows summing to $186,741,475,541 with VALUE read as dollars as filed, 13F file number 028-10904. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJANUS HENDERSON INVESTORS UK Ltd028-10906
- included managerJANUS HENDERSON INVESTORS US LLC028-01343
- included managerJanus Henderson Investors (Australia) Institutional Funds Management Ltd028-20157
- included managerJanus Henderson Investors (Singapore) Ltd028-20257
- included managerJanus Henderson Investors (Jersey) Ltd028-21345
- included managerEquitable Investment Management Group, LLC028-14633
- included managerPark Avenue Institutional Advisers LLC028-16979
- included managerGuideStone Capital Management, LLC028-10998
- included managerNEW YORK LIFE INVESTMENT MANAGEMENT LLC028-06325
- included managerNationwide Fund Advisors028-05161
- included managerNORTHERN TRUST CORP028-00290
- included managerPacific Life Fund Advisors LLC028-14003
- included managerPenn Mutual Asset Management028-18923
- included managerFIRST TRUST ADVISORS LP028-06487
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 68,500 | $98,298 | dollars as filed | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 38,107 | $98,126 | dollars as filed | |
| ACCOLADE INC | 00437E102 | COM | 27,031 | $97,176 | dollars as filed | |
| 1 800 FLOWERS COM INC | 68243Q106 | CL A | 10,035 | $95,533 | dollars as filed | |
| DEFINITIVE HEALTHCARE CORP | 24477E103 | CLASS A COM | 16,434 | $89,647 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 21,172 | $86,699 | dollars as filed | |
| GPGI INC COM CL A | 20459V105 | Stock | 12,286 | $83,545 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 15,031 | $73,276 | dollars as filed | |
| SERITAGE GROWTH PPTYS | 81752R100 | CL A | 14,079 | $65,819 | dollars as filed | |
| GRAB HOLDINGS LIMITED | G4124C117 | *W EXP 99/99/999 | 403,754 | $64,601 | dollars as filed | |
| ANGI INC CLASS A | 00183L102 | CL A | 29,250 | $56,014 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 11,200 | $50,344 | dollars as filed | |
| OPAL FUELS INC | 68347P103 | CLASS A COM | 11,842 | $48,434 | dollars as filed | |
| CERENCE INC COM | 156727109 | Stock | 16,919 | $47,796 | dollars as filed | |
| HERITAGE GLOBAL INC | 42727E103 | COM | 18,914 | $46,528 | dollars as filed | |
| SACHEM CAP CORP | 78590A109 | COM | 13,164 | $34,095 | dollars as filed | |
| MULTIPLAN CORPORATION | 62548M100 | COM | 70,711 | $27,850 | dollars as filed | |
| NEBIUS GROUP N.V. | N97284108 | SHS CLASS A | 15,658 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-24-003869 | this filing | 2024-08-14 | acceptance time not in the bulk data set |